Good news on vaccine trials for children!

Breaking News: A Pfizer-BioNTech trial found the vaccine extremely effective in 12- to 15-year-olds, with no coronavirus infections among children who received it.https://t.co/l37VNblWSE

— The New York Times (@nytimes) March 31, 2021